DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Small Molecule Drugs cited in Simonian v. Allergan, Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2010-11-30||45||products with two expired patents, namely U.S. Patent Numbers 4,839,342 (“the ‘342 patent”) and 4,649,047 (“…expired ‘342 and ‘047 patents, the product was also marked with a separate patent that is both valid and… is marked with unexpired U.S. Patent No. 5,474,979 (“the ‘979 patent”), Defendant submits that the Court…with an expired patent regardless of whether the article is also marked by valid patents, the Court denies…litigation of patent infringement cases and which regularly prosecutes or oversees patent prosecution.||External link to document|
|2011-04-28||70||products with two expired patents, namely U.S. Patent Numbers 4,839,342 (“the ‘342 patent”) and 4,649,047 (“…litigation of patent infringement cases and which regularly prosecutes or oversees patent prosecution.…article with an expired patent, even if it also marked that article with valid patents. (Id.) On… of the U.S. Patent and Trademark Office (“PTO”) after the filing of any type of patent action, is generic…(“the ‘047 patent”). (R. 1.) On March 4, 2011, Allergan filed a motion for judgment on the pleadings,||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|